This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

ApoA-1 deficiency

Authoring team

Complete ApoA-I Deficiency Familial apolipoprotein A-I (apoA-I) defects may be caused by complete deficiency of the apoA-I gene or by mutations in the apoA-I gene.

  • genetic deficiency of apoA-I may be due to the deletion of the gene or to nonsense mutations that prevent the synthesis of apoA-I protein, which results in an absence of plasma high-density lipoprotein (HDL)
  • p atients with this disorder sometimes display cutaneous xanthomas. The risk of premature cardiovascular disease in patients with apoA-I deficiency may be increased, but the onset of symptoms varies from the third to the seventh decade

References:

  1. Norum RA, Lakier JB, Goldstein S, et al. Familial deficiency of apolipoproteins A-I and C-III and precocious coronary-artery disease. N Engl J Med. 1982;306:1513–1519.
  2. Schaefer EJ, Heaton WH, Wetzel MG, Brewer HB Jr. Plasma apolipoprotein A-1 absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease. Arteriosclerosis. 1982;2:16–26.
  3. Ng D, Leiter L, Vezina C, et al. Apolipoprotein A-1 Q[-2]X causing isolated apolipoprotein A-1 deficiency in a family with analphalipoproteinemia. J Clin Invest. 1994;93:223–229.
  4. Breslow JL. Familial disorders of high-density lipoprotein metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. 7th ed. New York: McGraw-Hill; 1995:2031–2052.

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.